|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 39-48, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
AJ Roberts, DA Hay, JL Mehta, P Mehta, L Roy, RS Faro, DG Knauf and JA Alexander
Factors associated with early and late graft patency related to aorta-
coronary artery bypass grafting with a reversed segment of saphenous vein
are clinically important. The present investigation examines the
biochemical and electron microscopic integrity of this venous conduit
intraoperatively with regard to pharmacologic manipulation with papaverine.
Portions of saphenous vein were analyzed in 22 patients undergoing coronary
artery bypass operations. Levels of a stable derivative of prostacyclin,
6-keto-PGF1 alpha, were measured by radioimmunoassay. Scanning as well as
transmission electron microscopy was also performed. In particular, the
efficacy of local vein treatment with papaverine, a phosphodiesterase
inhibitor, was evaluated. We found that levels of 6-keto-PGF1 alpha in
venous effluent showed a biphasic response with initial elevation followed
by a relative depression after papaverine exposure. There were no such
changes observed in veins subjected to a balanced electrolyte solution
(Plasma-Lyte). In addition, levels of the platelet-inhibitory substance
6-keto-PGF1 alpha in venous tissue were less in papaverine-treated veins
than those found in veins treated only with the balanced electrolyte
solution (Plasma- Lyte). Furthermore, evidence for ultrastructural damage
was also somewhat greater in the papaverine-treated group. An alternative
method of dilating the saphenous vein after harvesting, which involves the
creation of the proximal aorta-coronary anastomosis first and gentle finger
manipulation subsequently, appeared to minimize venous injury. Under
present clinical conditions, it appears that some amount of injury is
inevitable during harvesting and suturing of the human saphenous vein
during coronary bypass grafting.
ARTICLES
Biochemical and ultrastructural integrity of the saphenous vein conduit during coronary artery bypass grafting. Preliminary results of the effect of papaverine
This article has been cited by other articles:
![]() |
A. Schlitt, D. Pruefer, U. Buerke, M. Russ, M. Dahm, H. Oelert, K. Werdan, and M. Buerke Neutrophil Adherence to Activated Saphenous Vein and Mammary Endothelium After Graft Preparation Ann. Thorac. Surg., April 1, 2006; 81(4): 1262 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Liu, X.-C. Liu, A. P.C. Yim, and G.-W. He Direct measurement of nitric oxide release from saphenous vein: abolishment by surgical preparation Ann. Thorac. Surg., January 1, 2001; 71(1): 133 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Rosenfeldt, G.-W. He, B. F. Buxton, and J. A. Angus Pharmacology of coronary artery bypass grafts Ann. Thorac. Surg., March 1, 1999; 67(3): 878 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Roubos, F. L. Rosenfeldt, S. M. Richards, R. A.J. Conyers, and B. B. Davis Improved Preservation of Saphenous Vein Grafts by the Use of Glyceryl Trinitrate–Verapamil Solution During Harvesting Circulation, November 1, 1995; 92(9): 31 - 36. [Abstract] [Full Text] |
||||
![]() |
G.-W. He, B. F. Buxton, F. L. Rosenfeldt, J. A. Angus, and J. Tatoulis Pharmacologic dilatation of the internal mammary artery during coronary bypass grafting J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1440 - 1444. [Abstract] [Full Text] |
||||
![]() |
A. M. Sanchez, T. A. Wooldridge, L. E. Boerboom, G. N. Olinger, G. H. Almassi, and N. J. Rusch Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1445 - 1453. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |